R. Fengler

884 total citations
26 papers, 530 citations indexed

About

R. Fengler is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Hematology. According to data from OpenAlex, R. Fengler has authored 26 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 10 papers in Pediatrics, Perinatology and Child Health and 10 papers in Hematology. Recurrent topics in R. Fengler's work include Acute Lymphoblastic Leukemia research (17 papers), Childhood Cancer Survivors' Quality of Life (10 papers) and Acute Myeloid Leukemia Research (6 papers). R. Fengler is often cited by papers focused on Acute Lymphoblastic Leukemia research (17 papers), Childhood Cancer Survivors' Quality of Life (10 papers) and Acute Myeloid Leukemia Research (6 papers). R. Fengler collaborates with scholars based in Germany, United States and Netherlands. R. Fengler's co-authors include R. Hartmann, D. Niethammer, B. Kornhuber, H. Riehm, G. Janka‐Schaub, G. Henze, G. Henze, H. Riehm, Boris Zernikow and Norbert Grießinger and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Chemotherapy and Pharmacology.

In The Last Decade

R. Fengler

26 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Fengler Germany 10 421 280 245 91 63 26 530
Anna Berg Netherlands 7 348 0.8× 228 0.8× 247 1.0× 66 0.7× 60 1.0× 9 465
Adynel Wood United States 7 281 0.7× 135 0.5× 132 0.5× 109 1.2× 39 0.6× 8 422
Ulla Wartiovaara‐Kautto Finland 11 170 0.4× 187 0.7× 89 0.4× 70 0.8× 18 0.3× 41 411
Nazan Çetingül Türkiye 11 104 0.2× 120 0.4× 139 0.6× 48 0.5× 22 0.3× 36 408
J Cubells Spain 11 100 0.2× 159 0.6× 70 0.3× 41 0.5× 57 0.9× 22 279
Louise Chevalier France 10 146 0.3× 65 0.2× 97 0.4× 55 0.6× 33 0.5× 17 341
C Bender-Götze Germany 8 146 0.3× 200 0.7× 83 0.3× 39 0.4× 19 0.3× 16 268
Andrés Gómez‐De León Mexico 12 100 0.2× 267 1.0× 51 0.2× 86 0.9× 20 0.3× 96 436
Weinberg United States 7 129 0.3× 72 0.3× 66 0.3× 37 0.4× 20 0.3× 19 284
P. Kajtár Hungary 11 79 0.2× 48 0.2× 77 0.3× 62 0.7× 38 0.6× 30 304

Countries citing papers authored by R. Fengler

Since Specialization
Citations

This map shows the geographic impact of R. Fengler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Fengler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Fengler more than expected).

Fields of papers citing papers by R. Fengler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Fengler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Fengler. The network helps show where R. Fengler may publish in the future.

Co-authorship network of co-authors of R. Fengler

This figure shows the co-authorship network connecting the top 25 collaborators of R. Fengler. A scholar is included among the top collaborators of R. Fengler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Fengler. R. Fengler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fengler, R., et al.. (2006). Action potential simulation (APS) in patients with fibromyalgia syndrome (FMS): a controlled single subject experimental design. Clinical Rheumatology. 26(3). 322–329. 6 indexed citations
2.
Zernikow, Boris, Christine Schießl, C. Wamsler, et al.. (2006). Praktische Schmerztherapie in der pädiatrischen Onkologie. Der Schmerz. 20(1). 24–39. 5 indexed citations
4.
Zernikow, Boris, Norbert Grießinger, & R. Fengler. (1999). Praktische Schmerztherapie in der Kinderonkologie. Monatsschrift Kinderheilkunde. 147(5). 438–456. 9 indexed citations
6.
Fengler, R., et al.. (1994). Schwere renale Methotrexat-Ausscheidungsstörung nach Hochdosis-Therapie. Klinische Pädiatrie. 206(4). 319–326. 18 indexed citations
7.
Reiter, Alfred, Martin Schrappe, Elif Yakisan, et al.. (1994). Therapiestudie NHL-BFM 90 zur Behandlung maligner Non-Hodgkin-Lymphome bei Kindern und Jugendlichen - Teil 2: Eine Zwischenanalyse der Therapiegruppe Non-B-NHL. Klinische Pädiatrie. 206(4). 234–241. 11 indexed citations
10.
Fengler, R., et al.. (1990). Syndrome of the posterior and anterior root in a late isolated CNS relapse of c-ALL. Case report. Neurosurgical Review. 13(1). 73–75. 1 indexed citations
11.
Henze, G., R. Fengler, R. Hartmann, et al.. (1990). BFM Group Treatment Results in Relapsed Childhood Acute Lymphoblastic Leukemia. Hämatologie und Bluttransfusion. 33. 619–626. 17 indexed citations
12.
Hartmann, Robert C., et al.. (1990). Einfluß der 7S-Immunglobulin Substitution auf die Häufigkeit und den Verlauf von Infektionen bei zytostatisch behandelten Patienten. Klinische Pädiatrie. 202(4). 275–277. 1 indexed citations
13.
Henze, G., R. Fengler, Alfred Reiter, J. Ritter, & H. Riehm. (1990). Impact of Early Intensive Reinduction Therapy on Event-Free Survival in Children with Low-Risk Acute Lymphoblastic Leukemia. Hämatologie und Bluttransfusion. 33. 483–488. 19 indexed citations
14.
Fengler, R., R. Hartmann, U. Bode, et al.. (1990). Risk of CNS Relapse After Systemic Relapse of Childhood Acute Lymphoblastic Leukemia. Hämatologie und Bluttransfusion. 33. 511–515. 6 indexed citations
15.
Wegner, R.‐D., et al.. (1989). Calla-Positive Acute Leukaemia with t(5q;14q) Translocation and Hypereosinophilia – A Unique Entity?. Acta Haematologica. 82(2). 85–90. 12 indexed citations
16.
Fengler, R., et al.. (1989). Ototoxizität von Cisplatin bei Kindern mit malignen Erkrankungen. Klinische Pädiatrie. 201(4). 316–321. 1 indexed citations
17.
Henze, G., R. Fengler, R. Hartmann, et al.. (1989). Chemotherapy for bone marrow relapse of childhood acute lymphoblastic leukemia. Cancer Chemotherapy and Pharmacology. 24(S1). S16–9. 9 indexed citations
18.
Henze, G., et al.. (1987). The BFM Relapse Studies in Childhood ALL: Concepts of Two Multicenter Trials and Results after 21/2 Years. Hämatologie und Bluttransfusion. 30. 147–155. 8 indexed citations
19.
Henze, G., et al.. (1986). Erste Ergebnisse einer Studie zur Behandlung von Kindern mit ALL-Rezidiven. Oncology Research and Treatment. 9(2). 92–95. 3 indexed citations
20.
Fengler, R., et al.. (1986). Biklonale Leukämie (O-ALL/AMoL) mit 11;19 Translokation und Trisomie X bei einem 8 Monate alten Mädchen*. Klinische Pädiatrie. 198(3). 178–182. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026